Web Analytics

3 Latest Announced Rounds

  • $12,000,000
    Unknown
    Software Development
    May 2nd, 2025
  • $39,548,022
    Series C
    Medical Device
    May 2nd, 2025
  • $4,800,000
    Unknown
    Maritime Transportation
    May 2nd, 2025
$1,100.39M Raised in 52 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ability Biologics

start up
Canada - Montreal, Quebec
  • 07/12/2023
  • Seed
  • $12,000,000

Our Mission:
Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.

The premier biotherapeutic targeting company

Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics.

We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.


Related People

Giles DayCo Founder

Giles Day United States - South San Francisco, California

N/A